Accessibility of malaria commodities in Geita District Council, mainland Tanzania: the experiences from healthcare providers and clients
Anna David, Omary Swalehe, Jean D’ Amour Habagusenga, Stany Banzimana, Domina Asingizwe, Frank Chacky, Fabrizio Molteni

TL;DR
This study examines why malaria medicines are not consistently available in health facilities in Tanzania, finding that government facilities face delivery delays while private facilities struggle with costs.
Contribution
The study provides new insights into the specific logistical and financial barriers affecting malaria commodity accessibility in different types of health facilities in Tanzania.
Findings
Government facilities had 100% availability of malaria commodities, but faced issues with delayed deliveries.
Private and faith-based facilities had availability ranging from 10% to 80%, with stockouts due to lack of funds.
High costs and poor stocking levels prevent patients from receiving complete malaria treatment in private facilities.
Abstract
Access to essential malaria commodities is a cornerstone in malaria control. However optimal availability and access to essential malaria commodities remain a challenge in Tanzania. Therefore, this study aimed to explore the factors affecting the accessibility of malaria commodities in Tanzania. This was a mixed-method cross-sectional study using both quantitative and qualitative approaches. Data were collected between February and March 2023 from health facilities, health facility staff, and patients. Availability of malaria commodities in government health facilities was 100% for all items while in the private and faith-based facilities, this ranged from 10% to 80%. The reasons for stockouts in Government facilities were related to delayed and inadequate quantity delivery while in private facilities the main reason was the lack of cash for procurement. Both private facilities’…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsGlobal Maternal and Child Health · Pharmaceutical Economics and Policy · HIV/AIDS Impact and Responses
